(RSV) is a common cause of lower respiratory tract infection (LRTI) and is responsible for a high burden of hospital admission and mortality in children. RSV–LRTI is also associated with long-term ...

Every year, millions of infants are infected by a little-known virus that is the most common cause of respiratory disease in children. Respiratory syncytial virus (RSV) (Fig. 1) causes a spectrum ...

GSK released data from a Phase 3 trial evaluating the co-administration of Arexvy and Shingrix vaccines in adults 50+. The ...

RSV, or respiratory syncytial virus, is a common cause of coughs and colds which can also lead to severe lung infections like pneumonia and infant bronchiolitis – conditions which are highly ...

AS the new life-saving Respiratory Syncytial Virus (RSV) vaccination programme aimed at protecting newborns and older adults ...

Since the pandemic, health officials have approved new vaccines to help Americans combat severe symptoms from COVID-19, respiratory syncytial virus, or RSV, and influenza. Experts urge eligible ...

After decades of research, vaccines protecting against respiratory syncytial virus, or RSV, made their debut last year. The highly contagious virus usually causes mild symptoms. But in some cases ...

The good news is that even as cases rise and will likely continue to, new as well as tried and true vaccines are available to target COVID-19, influenza and respiratory syncytial virus ...

The NHS has started vaccinating pregnant women and older people against a respiratory virus that can make some people seriously ill. Officials suggest the respiratory syncytial virus (RSV ...

The following is a summary of “Respiratory viral infections from 2015 to 2022 in the HIVE cohort of American households: Incidence, illness characteristics, and seasonality,” published in the August ...

Respiratory syncytial virus (RSV) infections are the leading cause of viral death in infants, although RSV-related mortality has decreased since the development and approval of prophylactic ...